Nate Crossett

Stock Analyst at Exane BNP Paribas

(1.92)
# 3,197
Out of 5,044 analysts
38
Total ratings
50%
Success rate
1.24%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Mar 12, 2025
Upgrades: Outperform
Price Target: $5$9
Current: $4.86
Upside: +85.19%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $39.53
Upside: -24.11%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $73.09
Upside: -12.44%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $18.77
Upside: -9.43%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $58.36
Upside: +7.95%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $58.76
Upside: +83.80%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $69.78
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $167.14
Upside: -17.43%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $123.47
Upside: +14.20%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $43.65
Upside: +44.33%
Initiates: Underperform
Price Target: $42
Current: $41.11
Upside: +2.16%
Initiates: Outperform
Price Target: $41
Current: $29.70
Upside: +38.05%
Initiates: Outperform
Price Target: $29
Current: $30.19
Upside: -3.94%
Initiates: Underperform
Price Target: $74
Current: $66.28
Upside: +11.65%
Initiates: Outperform
Price Target: n/a
Current: $14.56
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $7.56
Upside: +26.98%
Initiates: Outperform
Price Target: $66
Current: $101.34
Upside: -34.87%
Initiates: Outperform
Price Target: $38
Current: $12.54
Upside: +203.03%
Initiates: Outperform
Price Target: $886
Current: $797.73
Upside: +11.07%
Downgrades: Hold
Price Target: $31$30
Current: $23.45
Upside: +27.93%
Initiates: Buy
Price Target: $21
Current: $15.32
Upside: +37.08%
Downgrades: Hold
Price Target: $21$25
Current: $9.11
Upside: +174.42%
Upgrades: Buy
Price Target: n/a
Current: $37.68
Upside: -